Skip To Main Content
Katia Abarca on Muck Rack

Katia Abarca

As seen in: MDPI, Medscape, EClinicalMedicine, Pediatrics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Katia

Contact Katia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile

|
By Nicole Le Corre, Katia Abarca, Patricio Astudillo, Marcela Potin
| MDPI
1. Introduction Since 2020, the COVID-19 pandemic has been responsible for millions of infected people and deaths worldwide [1]. By the end of 2020, more than 84 million people had confirmed COVID-19 and close to 2 million related deaths were reported to the World Health Organization (WHO) [2]. Older age, obesity, and immunocompromise were the main risk factors to developing a severe disease [3].
Open in Who Shared Issue with article?

Scrub Typhus Outbreak -- Los Lagos Region, Chile

|
By Thomas Weitzel, Constanza Martínez-Valdebenito, Gerardo Acosta-Jamett, Katia Abarca
| Medscape Verified
Authors and Disclosures Thomas Weitzel, MD1,2,*, Constanza Martínez-Valdebenito, MSc3,4,*, Gerardo Acosta-Jamett, PhD5 and Katia Abarca, MD3,4 1Laboratorio Clínico, Clínica Alemana, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago, Chile; 2Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile; 3Departamento de Enfermedades Infecciosas e Inmunología Pediátricas, Escuela de Medicina, Pontificia...
Open in Who Shared Issue with article?

Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial

|
By Susan Bueno, Katia Abarca, Pablo Gonzalez Verified, Nicolás MS Gálvez
| medRxiv
View ORCID ProfileSusan M Bueno, View ORCID ProfileKatia Abarca, Pablo A González, View ORCID ProfileNicolás MS Gálvez, Jorge A Soto, View ORCID ProfileLuisa F Duarte, View ORCID ProfileBárbara M Schultz, View ORCID ProfileGaspar A Pacheco, Liliana A González, Yaneisi Vázquez, Mariana Ríos, Felipe Melo-González, Daniela Rivera-Pérez, Carolina Iturriaga, Marcela Urzúa, Angélica Dominguez, View ORCID ProfileCatalina A Andrade, Roslye V Berrios, Gisela Canedo-Marroquín, Camila Covián, Daniela...
Open in Who Shared Issue with article?
See all 6 licensed articles (7 Total)